PERKINS CAPITAL MANAGEMENT INC - Q1 2023 holdings

$106 Thousand is the total value of PERKINS CAPITAL MANAGEMENT INC's 97 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .

 Value Shares↓ Weighting
IDXX  IDEXX LABS INC$5,403
+22.6%
10,8050.0%5.09%
+9.5%
MSFT  MICROSOFT CORP$4,418
+20.2%
15,3260.0%4.17%
+7.4%
SKYT  SKYWATER TECHNOLOGY INC$1,593
+60.1%
140,0000.0%1.50%
+43.0%
ATRC  ATRICURE INC$1,382
-6.6%
33,3500.0%1.30%
-16.6%
TGT  TARGET CORP$1,238
+11.1%
7,4750.0%1.17%
-0.8%
BMY  BRISTOL-MYERS SQUIBB CO$1,084
-3.6%
15,6410.0%1.02%
-14.0%
CIEN  CIENA CORP$945
+2.9%
18,0000.0%0.89%
-8.0%
AAPL  APPLE INC$767
+27.0%
4,6500.0%0.72%
+13.3%
CSTL  CASTLE BIOSCIENCES INC$707
-3.4%
31,1100.0%0.67%
-13.7%
BLFS  BIOLIFE SOLUTIONS INC$696
+19.6%
32,0000.0%0.66%
+6.8%
DCI  DONALDSON INC$646
+11.0%
9,8840.0%0.61%
-0.8%
FAST  FASTENAL CO$518
+14.1%
9,6000.0%0.49%
+1.9%
USIO  USIO INC$492
+5.4%
282,8880.0%0.46%
-5.9%
ASUR  ASURE SOFTWARE INC$479
+55.5%
33,0000.0%0.45%
+39.1%
NXPI  NXP SEMICONDUCTOR N V$457
+18.1%
2,4500.0%0.43%
+5.4%
PRFT  PERFICIENT INC$411
+3.3%
5,7000.0%0.39%
-7.6%
CVS  CVS HEALTH CORP$393
-20.3%
5,2930.0%0.37%
-28.7%
JNJ  JOHNSON & JOHNSON$357
-12.1%
2,3000.0%0.34%
-21.4%
ANIP  ANI PHARMACEUTICALS INC$339
-1.2%
8,5260.0%0.32%
-11.6%
CYRX  CRYOPORT INC$276
+38.0%
11,5000.0%0.26%
+23.2%
LFVN  LIFEVANTAGE CORPORATION$273
-3.5%
76,1130.0%0.26%
-14.0%
MDT  MEDTRONIC PLC$210
+4.0%
2,6000.0%0.20%
-7.0%
LTRX  LANTRONIX INC$180
+0.6%
41,4000.0%0.17%
-10.1%
PRTK  PARATEK PHARMACEUTICALS INC$116
+36.5%
45,7000.0%0.11%
+21.1%
DYAI  DYADIC INTL INC DEL$86
+45.8%
48,1000.0%0.08%
+30.6%
AIRG  AIRGAIN INC$83
-17.8%
15,5000.0%0.08%
-27.1%
SENS  SENSEONICS HLDGS INC$36
-32.1%
51,0000.0%0.03%
-39.3%
IMBI  IMEDIA BRANDS INC$18
-21.7%
35,7000.0%0.02%
-29.2%
VERB  VERB TECHNOLOGY CO INC$1
-50.0%
12,0000.0%0.00%
-50.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-09
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NEOGENOMICS INC41Q3 20237.8%
LILY ELI & CO41Q3 20236.9%
PFIZER INC41Q3 20232.9%
ATTUNITY LTD41Q3 20233.6%
EXPEDITORS INTL WASH INC41Q3 20232.3%
CVS HEALTH CORP41Q3 20231.6%
DONALDSON INC41Q3 20231.3%
VERIZON COMMUNICATIONS INC41Q3 20231.0%
US BANCORP DEL41Q3 20230.8%
BAXTER INTL INC40Q3 202314.1%

View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.

Latest significant ownerships (13-D/G)
PERKINS CAPITAL MANAGEMENT INC Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
BIOLASE, INCMay 15, 2023689,1962.1%
FlexShopper, Inc.February 09, 20231,281,4605.9%
Avinger IncFebruary 14, 2020891,7615.2%
Black Ridge Oil & Gas, Inc.February 15, 201930,021,0326.3%
CANCER GENETICS, INCFebruary 15, 20191,135,2504.0%
TearLab CorpFebruary 15, 20191,666,29413.1%
Xtant Medical Holdings, Inc.February 15, 2019684,4083.6%
TearLab CorpJanuary 26, 20184,300,65540.1%
BIO KEY INTERNATIONAL INCFebruary 09, 2017274,9004.4%
EnteroMedics IncFebruary 09, 20171,4550.0%

View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-01-22
13F-HR2023-11-02
13F-HR2023-07-21
SC 13G/A2023-05-15
13F-HR2023-05-09
SC 13G/A2023-02-09
SC 13G2023-02-09
13F-HR2023-01-26
13F-HR2022-10-24
13F-HR2022-07-29

View PERKINS CAPITAL MANAGEMENT INC's complete filings history.

Compare quarters

Export PERKINS CAPITAL MANAGEMENT INC's holdings